<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890563</url>
  </required_header>
  <id_info>
    <org_study_id>131/2016</org_study_id>
    <nct_id>NCT02890563</nct_id>
  </id_info>
  <brief_title>Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy</brief_title>
  <official_title>Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oulu University Hospital</source>
  <brief_summary>
    <textblock>
      Study purpose is to research whether compression therapy is beneficial after truncal vein
      RF-ablation and distal sclerotherapy done in the same session when needed. Patients will be
      randomised to either no compression group (Group I) or compression group (Group II)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study two endpoints are anticipated, first endpoint is to assess safety and adverse
      effects between groups at 1 month endpoint. Also post-procedural pain and need for
      painkillers are monitored. Compliance and reasons for non-compliance is recorded in
      compression group.

      Second endpoint is to assess mid-term (6 months) success of truncal vein occlusion as well as
      changes in Aberdeen score between groups compared to pre-operative stage.

      Study design is non-inferiority trial where in 5% margin occlusion of truncal vein is
      expected to be equal in two groups at 6 six months. Power analysis showed need for 85
      patients per group and taking into account possible dropouts anticipated n = 200.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Truncal vein occlusion rate</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain assessed with visual analogue scale (VAS)</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Painkillers usage after treatment</measure>
    <time_frame>10 days</time_frame>
    <description>Need for Paracetamol/NSAIDs after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aberdeen Varicose Veins Questionnaire (AVVQ)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessed preoperatively and at one and six months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with compression stockings</measure>
    <time_frame>7 days</time_frame>
    <description>To assess compliance and possible reasons for non-compliance at compression group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time required returning to normal work and activity level</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signs of deep venous thrombosis, pigmentation, blisters, skin irritation, thrombophlebitis, hematoma, wound infection or paraesthesia post operatively</measure>
    <time_frame>30days</time_frame>
    <description>Assessed in 1month control and earlier if necessary (Patient is instructed to contact outpatient clinic in case of problems).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>No Compression</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will not receive any compression after treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compression</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will use compression stockings for seven days after treatment (2 days continuously and 5 days during daytime).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Class II Compression Stockings</intervention_name>
    <arm_group_label>Compression</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Duplex ultrasound verified GSV and/or SSV incompetence (0.5 seconds or more)

          -  Comprehensive Classification System for Chronic Venous Disorders (CEAP) rated from C2
             to C4

          -  Truncal vein insufficiency (GSV and/or SSV) treatable with Radiofrequency ablation

        Exclusion Criteria:

          -  History of pulmonary embolism or deep venous thrombosis

          -  Large (&gt;12mm) truncal vein diameter

          -  CEAP C5-C6

          -  Patient unwilling to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toni Pihlaja, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matti Pokela, Docent</last_name>
    <phone>+31583152011</phone>
    <email>matti.pokela@ppshp.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Raahe's hospital</name>
      <address>
        <city>Raahe</city>
        <state>Pohjois-Pohjanmaa</state>
        <zip>92101</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janne Jounila, M.D.</last_name>
      <phone>+3588849111</phone>
      <email>janne.jounila@ras.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital, Vascular Department</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Pokela, Docent</last_name>
      <phone>+35883152011</phone>
      <email>matti.pokela@ppshp.fi</email>
    </contact>
    <investigator>
      <last_name>Toni Pihlaja, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oulu University Hospital</investigator_affiliation>
    <investigator_full_name>Toni Pihlaja</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Varicose veins</keyword>
  <keyword>Compression stockings</keyword>
  <keyword>Sclerotherapy</keyword>
  <keyword>Radiofrequency ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

